BUPRENORPHINE-NALOXONE-INDUCED NONCARDIOGENIC PULMONARY EDEMA
Sign Up to like & getrecommendations! Published in 2021 at "Chest"
DOI: 10.1016/j.chest.2021.07.721
Abstract: TOPIC: Critical Care TYPE: Medical Student/Resident Case Reports INTRODUCTION: Buprenorphine-naloxone is used to treat chronic pain and opioid use disorder. Each medication in this combination has been associated with noncardiogenic pulmonary edema. Here we report… read more here.
Keywords: noncardiogenic pulmonary; pulmonary edema; edema; buprenorphine naloxone ... See more keywords
Naloxone-Induced Noncardiogenic Pulmonary Edema.
Sign Up to like & getrecommendations! Published in 2019 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000001037
Abstract: To the Editor: Naloxone is an opioid antagonist, used for rapid reversal of opioid effects. Naloxone has been known to cause adverse effects such as hypotension, arrhythmias, seizures, and rarely flash noncardiogenic pulmonary edema. A… read more here.
Keywords: edema; noncardiogenic pulmonary; pulmonary edema; pulmonary vascular ... See more keywords